Código QR

Hypertension among people living with HIV receiving dolutegravir-based antiretroviral therapy in ethiopia: a cross-sectional study

Abstract Recently, dolutegravir (DTG) has been associated with weight gain, dyslipidemia, and hyperglycemia, which in turn raise(s) the risk of hypertension. However, little is known about the burden of hypertension among people living with HIV (PLHIV) taking DTG-based therapy in Ethiopia. This stud...

Descrición completa

Gardado en:
Principais autores: Mohammed Jemal, Desalegn Abebaw, Yabibal Tsegaye Workineh, Worku Abie Liyew, Tabarak Malik, Adane Adugna
Formato: Artigo
Idioma:Inglês
Publicado: Nature Portfolio 2025-07-01
Series:Scientific Reports
Assuntos:
Hypertension
HIV
People living with HIV (PLHIV)
Dolutegravir (DTG)
ART
Acceso en liña:https://doi.org/10.1038/s41598-025-06145-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares